0

Lung Cancer Liquid Biopsy Market by Product, End-user, and Geography - Forecast and Analysis 2020-2024

  • Published: Oct 2020
  • Pages: 120
  • SKU: IRTNTR45510
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The lung cancer liquid biopsy market size will record an incremental growth of $ 292.89 mn and a CAGR of 16% during 2020-2024.

This market report entails segmentation by product (CTCs and ctDNA and Exosomes and RNA) and geography (North America, Europe, Asia, and ROW). View our sample report to gather market insights on the segmentations. 

The lung cancer liquid biopsy market report also analyzes the market’s competitive landscape and offers information on several market vendors, including Biocartis Group NV, Biocept Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., QIAGEN NV, Sysmex Corp., Thermo Fisher Scientific Inc., and Trovagene Inc..

What will the Lung Cancer Liquid Biopsy Market Size be in 2020?

View the TOC and LoE with selected illustrations and example pages of lung cancer liquid biopsy market

Request a FREE sample now!

Overview of Competitive Analysis

The lung cancer liquid biopsy market forecast report provides insights on complete key vendor profiles and their business strategies to reimage themselves. The profiles include information on the production, competitive landscape, sustainability, and prospects of the leading companies.

The market structure is fragmented. With the shift in consumer behavior owing to the COVID-19 pandemic, the vendors are focusing on leveraging upcoming trends and drivers that have been identified and explored in this lung cancer liquid biopsy market analysis report. Factors such as the Rising incidence of lung cancer | Increasing participation in conferences to endorse the products | Technologically advanced products will offer immense growth opportunities. The report also covers challenges and strategies to dodge them, which will help vendors in recreating their plan of action to obtain growth opportunities in the future.

To make the most of the opportunities, vendors should also capitalize on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Fetch actionable market insights on post-COVID-19 impact on each product and service segments.

Which are the Key Regional Markets for Lung Cancer Liquid Biopsy Market?

For more lung cancer liquid biopsy market insights of various regions Request a FREE sample now!

The report offers an up-to-date analysis of the geographical composition of the market. North America had the largest market share in the lung cancer liquid biopsy market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The Growing partnership agreements | Application of liquid biopsy for personalized treatment will significantly influence lung cancer liquid biopsy market growth in this region. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report

49% of the market’s growth will originate from North America during the forecast period. US | Germany | France | UK | Japan | China are the key markets for lung cancer liquid biopsy market in the region. This report provides estimations of the contribution of all regions to the growth of the lung cancer liquid biopsy market size.

Event-Tickets-Market-Report

Request for a FREE sample

What are the Key Factors Covered in this Lung Cancer Liquid Biopsy Market Report?

  • CAGR of the market during the forecast period 
  • Detailed information on factors that will drive lung cancer liquid biopsy market growth during the next five years
  • Precise estimation of the size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the lung cancer liquid biopsy market industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of lung cancer liquid biopsy market vendors

Need a Customized Report? Get in touch

Lung Cancer Liquid Biopsy Market Scope

Report Coverage

Details

Page number

120

Base year

2019

Forecast period

2020-2024

Growth momentum & CAGR

Accelerate at a CAGR of 16%

Market growth 2020-2024

$ 292.89 million

Market structure

Fragmented

YoY growth (%)

14.74

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 49%

Key consumer countries

US, Germany, France, UK, Japan, and China

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Biocartis Group NV, Biocept Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., QIAGEN NV, Sysmex Corp., Thermo Fisher Scientific Inc., and Trovagene Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2019
    • Market outlook: Forecast for 2019 - 2024

    Five Forces Analysis

    • Five Forces Summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Product

    • Market segments
    • Comparison by Product
    • CTCs and ctDNA - Market size and forecast 2019-2024
    • Exosomes and RNA - Market size and forecast 2019-2024
    • Market opportunity by Product

    Market Segmentation by End-user

    • Market segments
    • Comparison by End-user
    • Clinical diagnostic laboratories - Market size and forecast 2019-2024
    • Hospitals and clinics - Market size and forecast 2019-2024
    • Physicians' office laboratories - Market size and forecast 2019-2024
    • Market opportunity by End-user

    Customer Landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • North America - Market size and forecast 2019-2024
      • Europe - Market size and forecast 2019-2024
      • Asia - Market size and forecast 2019-2024
      • ROW - Market size and forecast 2019-2024
      • Key leading countries
      • Market opportunity by geography
      • Volume drivers – Demand led growth
      • Market challenges
      • Market trends

      Vendor Landscape

      • Vendor landscape
      • Landscape disruption

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • Biocartis Group NV
      • Biocept Inc.
      • Bio-Rad Laboratories Inc.
      • Bio-Techne Corp.
      • F. Hoffmann-La Roche Ltd.
      • Illumina Inc.
      • QIAGEN NV
      • Sysmex Corp.
      • Thermo Fisher Scientific Inc.
      • Trovagene Inc.

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Framework

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      TechnavioINFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases
      Technavio

      TechnavioDATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts
      Technavio

      TechnavioREPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape
      Interested in this report?
      Get your FREE sample now!
      The lung cancer liquid biopsy market growth will increase by $292.89 million during 2019-2024.
      The lung cancer liquid biopsy market is expected to grow at a CAGR of 16.32% during 2019-2024.
      Technavio has segmented the lung cancer liquid biopsy market by product (CTCs and ctDNA and Exosomes and RNA) ,end user (Clinical diagnostic laboratories and Hospitals and clinics) , and geographic (North America, Europe, Asia, and ROW).
      Biocartis Group NV, Biocept Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., QIAGEN NV, Sysmex Corp., Thermo Fisher Scientific Inc., Trovagene Inc. are a few of the key vendors in the lung cancer liquid biopsy market.
      North America will register the highest growth rate of 49.28% among the other regions. Therefore, the lung cancer liquid biopsy market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
      The key factors driving the lung cancer liquid biopsy market growth are:
      • Rising incidence of lung cancer
      • Growing partnership agreements
      The lung cancer liquid biopsy market vendors should focus on grabbing business opportunities from the ctcs and ctdna segment as it accounted for the largest market share in the base year.
      Safe and Secure SSL Encrypted
      Technavio

      Single User:

      2500 USD

      Technavio Get the report (PDF) sent to your email within minutes.

      Subscribe & Save

      Get lifetime access to our
      Technavio Insights

      Want to customize this report?

      This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

      We offer $1000 worth of FREE customization at the time of purchase
      Technavio
      Enquire Before Buying
      1. Home
      2. Health Care
      3. Published Report
      17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>